CD274 and neoplasm: Combined application of PD‐1/PD‐L1 antibody and TIM‐3 antibody can better inhibit tumor growth, suggesting that the upregulation of Tim‐3 expression may be involved in the acquired resistance of PD‐1 blocker.17